Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman, Irina Lambertz, Nurten Yigit, Liesbeth Vercruysse, Ali Rihani, Martin Michaelis, Jindrich Cinatl, Claude A. Cuvelier, Jean-Christophe Marine, Anne De Paepe, Marc Bracke, Frank Speleman, Jo Vandesompele
November 2009
PDF DOI
Type
Journal article
Publication
JNCI: Journal of the National Cancer Institute
Tom Van Maerken
Tom Van Maerken
PostDoctoral Fellow
Nurten Yigit
Nurten Yigit
Lab Technician

indispensable talent :-)

Liesbeth Vercruysse
Liesbeth Vercruysse
Lab Technician
Ali Rihani
Ali Rihani
(Post)Doctoral Fellow (09/2008-12/2014)
Jo Vandesompele
Jo Vandesompele
Professor

RNA addict trying to connect all the dots